Langerhans Cell Histiocytosis With Hypothalamic-pituitary and Bone Involvement: A Report of 2 Cases
Open Access
- 10 February 2025
- journal article
- case report
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 3 (3) , luaf017
Abstract
Case 1: A 31-year-old woman presented with secondary amenorrhea, polyuria, and polydipsia. Three years later, magnetic resonance imaging of the brain done for headaches found thickening of the pituitary infundibulum. Laboratory evaluation indicated central vasopressin deficiency, mild hyperprolactinemia, and central hypogonadism. Six months later, progression of the infundibular lesion was documented, now contacting the optic chiasm. Biopsy showed epithelioid histiocytes, chronic inflammation, and gliosis. On postoperative scan, a lesion in the parietal calvaria was identified, which was solitary on a bone scan. The patient received cytarabine for 12 months with resolution of infundibular and bone lesion on positron emission tomography-computed tomography scan 1 year later. Case 2: A 23-year-old man presented with polyuria, polydipsia, and unilateral tinnitus. Laboratory evaluation indicated vasopressin deficiency and central hypogonadism. External ear canal biopsy indicated an infiltrative lesion with eosinophils, small lymphocytes and histiocytes. Magnetic resonance of the brain revealed hypothalamic/infundibular and parietal and mastoid bone lesions; no other lesions were identified on positron emission tomography-computed tomography. Patient received cytarabine for 1 year with resolution of lesions, which was maintained during follow-up of 4 years. Although rare, Langerhans cell histiocytosis in adults should be considered in the appropriate clinical scenario. Multidisciplinary treatment is required.Keywords
This publication has 14 references indexed in Scilit:
- Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013–2019British Journal of Haematology, 2022
- Experiences of a Single Center in One Hundred Ninety-Four Adult Patients With Langerhans Cell HistiocytosisJournal of Hematology, 2022
- International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsBlood, 2022
- Langerhans cell histiocytosisBlood, 2020
- A case of multisystem Langerhans cell histiocytosis presenting as central diabetes insipidusJournal of Community Hospital Internal Medicine Perspectives, 2019
- Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosisEuropean Journal of Endocrinology, 2019
- Central diabetes insipidus: beware of Langerhans cell histiocytosis!2018
- Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomesBritish Journal of Haematology, 2017
- Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2000
- Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidusJournal of Endocrinological Investigation, 1998